Last reviewed · How we verify
LEQEMBI — mechanism of action
How LEQEMBI works
| Molecular target | Amyloid beta A4 protein |
|---|---|
| Drug class | Amyloid Beta-directed Antibody [EPC] |
See also
- Full profile: LEQEMBI
- Side effects: /side-effects
- Dosage & administration: /dosage
- Cost & pricing: /cost
- Drug interactions: /interactions
- Clinical trials: /clinical-trials
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing